SKIP001137 |
SKIP ID |
SKIP001137 |
Organism(En) |
- |
Organism(Ja) |
- |
Cell Type(En) |
- |
Cell Type(Ja) |
- |
Cell Tissue(En) |
hepatic fibroblast |
Cell Tissue(Ja) |
hepatic fibroblast |
Cell Origin |
Normal |
Cell Name 1(En) |
ATCC-HYR0103 |
Cell Name 1(Ja) |
ATCC-HYR0103 |
Cell Name 2(En) |
- |
Cell Name 2(Ja) |
- |
Disease Name 1(Ja) |
- |
ICD Code 1 |
- |
Disease Name 1(En) |
- |
OMIM1 |
- |
Disease Name 2(Ja) |
- |
ICD Code 2 |
- |
Disease Name 2(En) |
- |
OMIM 2 |
- |
Disease Name 3(Ja) |
- |
ICD Code 3 |
- |
Disease Name 3(En) |
- |
OMIM 3 |
- |
Age |
31 |
Age Range |
30-39 |
Sex |
Male |
Race(En) |
- |
Race(Ja) |
- |
Genetic Diagnosis |
-- |
Not Detected |
No |
Description(En) |
Normal iPS cell line |
Description(Ja) |
健常人由来iPS細胞株 |
Cell Morphology |
human ES-like |
Grade |
Research Grade |
Vector |
Retrovirus |
Transgene |
Oct4, Sox2, Klf4, Myc |
Adhesiveness |
- |
Feeder |
-- |
Feeder Cell |
- |
Medium |
Pluripotent Stem Cell SFM XF/FF, ATCC ACS-3002 |
Genome Editing |
- |
CO2 |
5% |
Mycoplasma |
- |
Detection of Contaminants Mycoplasma |
- |
Pluripotent Markers |
- |
Pluripotent Markers Assay |
- |
in vitro Differentiation |
- |
in vitro Differentiation Assay |
- |
in vivo Differentiation |
- |
in vivo Differentiation Assay |
- |
Other 1 Assay |
- |
Other 1 Assay Method |
- |
Other 2 Assay |
- |
Other 2 Assay Method |
- |
Other 3 Assay |
- |
Other 3 Assay Method |
- |
Karyotype |
- |
Karyotype Assay |
- |
Remaining Vector Detection |
- |
Remaining Vector Detection Assay |
- |
STR |
- |
HLA |
- |
Stem Cell Transcriptome analysis |
- |
Stem Cell Transcriptome analysis Assay |
- |
Author Name(En) |
Summit Pharmaceuticals Intl. Corp. |
Author Name(Ja) |
住商ファーマインターナショナル株式会社 |
Author Organization(En) |
Summit Pharmaceuticals Intl. Corp. |
Author Organization(Ja) |
住商ファーマインターナショナル株式会社 |
Author Contact Email |
atcc[at]summitpharma[dot]co[dot]jp |
PI Organization(En) |
American Type Culture Collection (ATCC) |
PI Organization(Ja) |
American Type Culture Collection (ATCC) |
PI Name(En) |
American Type Culture Collection (ATCC) |
PI Name(Ja) |
American Type Culture Collection (ATCC) |
PI Contact Email |
Tech[at]atcc[dot]org |
Availability |
Available |
Provider Organization(En) |
Summit Pharmaceuticals Intl. Corp. |
Provider Organization(Ja) |
住商ファーマインターナショナル株式会社 |
Provider Email |
atcc[at]summitpharma[dot]co[dot]jp |
Provider URL |
http://www.summitpharma.co.jp |
Ethical Statement(En) |
- |
Ethical Statement(Ja) |
- |
Terms of Use(En) |
- |
Terms of Use(Ja) |
- |
PubMed ID |
- |
DOI |
- |
Title |
- |
Authors |
- |
Journal |
- |
Year |
- |
Volume |
- |
Issue |
- |
Pages |
- |
URL |
- |
Free input |
- |
Note |
ATCC iPSCs have been adapted to feeder- and serum-free culture conditions. |